TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Luteolin, Gemcitabine
Phytochemical Name Luteolin (PubChem CID: 5280445 )
Anticancer drug Name Gemcitabine (PubChem CID: 60750 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 849
Pair Name Luteolin, Gemcitabine
Disease Info [ICD-11: 2C10.0] Pancreatic ductal adenocarcinoma Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Expression CASP3 hsa836
Down-regulation Expression CDH13 hsa1012
Down-regulation Expression GSK3B hsa2932
Down-regulation Expression KRAS hsa3845
In Vitro Model BxPC-3 Pancreatic ductal adenocarcinoma Homo sapiens (Human) CVCL_0186
In Vivo Model Male athymic nude mice were inoculated with BxPC-3 cells (1×10⁶ cells/mouse) cells
Result Luteolin + Gem promoted apoptotic cell death in pancreatic tumor cells in vivo through inhibition of the K-ras/GSK-3β/NF-κB signaling pathway, leading to a reduction in the Bcl-2/Bax ratio, release of cytochrome c, and activation of caspase 3.
03. Reference
No. Title Href
1 Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model. Pancreas. 2015 Jan;44(1):144-51. doi: 10.1097/MPA.0000000000000215. Click
It has been 46461 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP